Clinical Trial

Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial

Study acronym: ScreenUrSelf
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of the ScreenUrSelf trial is to increase cervical cancer screening attendance and compliance to follow-up by offering a first-void urine self-sampling alternative to women who are currently not participating in the organized cervical cancer screening program (defined in this project as un(der)-screened women), either on the woman or her physician's personal initiative, or by responding on the invitation letter.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-10.
Status change: Recruiting → Active, Not Recruiting 2025-06-10
Trial Details
NCT Number NCT05996783
Lead Sponsor Universiteit Antwerpen
Collaborators: Antwerp University Hospital (UZA), Centre for Cancer Detection (CvKO), Sciensano
Conditions Cervix Cancer, Cervical Intraepithelial Neoplasia, Human Papilloma Virus, HPV-Related Cervical Carcinoma
Enrollment 48,000 participants
Start Date 2023-05-25
Primary Completion 2024-03-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-13